Study of ZIO-101 in Multiple Myeloma

Clinical trial NCT00303199 · COMPLETED

Trial details

NCT number: NCT00303199
Sponsor: Alaunos Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-01-01
Primary completion: 2007-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.